Citation: Cm. Owen et Pv. Harrison, Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody, CLIN EXP D, 25(3), 2000, pp. 195-197
Authors:
Lewis, K
Gilmour, E
Harrison, PV
Patefield, S
Dickinson, Y
Manning, D
Griffiths, C
Citation: K. Lewis et al., Digital teledermatology for skin tumours: a preliminary assessment using areceiver operating characteristics (ROC) analysis, J TELEMED T, 5, 1999, pp. 57-58
Authors:
Mellerio, JE
Ashton, GHS
Mohammedi, R
Lyon, CC
Kirby, B
Harman, KE
Salas-Alanis, JC
Atherton, DJ
Harrison, PV
Griffiths, WAD
Black, MM
Eady, RAJ
McGrath, JA
Citation: Je. Mellerio et al., Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa, J INVES DER, 112(6), 1999, pp. 984-987
Citation: A. Sinha et Pv. Harrison, The prevalence of latex allergy among hospital employees in north-west England, BR J DERM, 140(3), 1999, pp. 567-567
Citation: B. Kirby et Pv. Harrison, Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis, BR J DERM, 140(1), 1999, pp. 186-187